Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Self-induced hyperinsulinaemia |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Drug-induced hyperinsulinemia |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Alimentary hyperinsulinaemia |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Hyperinsulinæmi forårsaget af insulinom |
Is a |
False |
Hyperinsulinism |
Inferred relationship |
Some |
|
Functional hyperinsulinism |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Impaired glucose tolerance with hyperinsulism |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
persisterende hyperinsulinæmisk hypoglykæmi i spædbarnsalderen |
Is a |
False |
Hyperinsulinism |
Inferred relationship |
Some |
|
Persistent hyperinsulinemic hypoglycemia of infancy (disorder) |
Is a |
False |
Hyperinsulinism |
Inferred relationship |
Some |
|
Ectopic hyperinsulinism |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Iatrogenic hyperinsulinism |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Anden hyperinsulinisme |
Is a |
False |
Hyperinsulinism |
Inferred relationship |
Some |
|
Idiopathic transient neonatal hyperinsulinaemia |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare form of congenital diazoxide-sensitive diffuse hyperinsulinism characterized by episodes of hypoglycemia induced by exercise due to an inappropriate lactate and pyruvate sensitivity in pancreatic beta-cells. Presentation is of recurring episodes of hypoglycemia associated with elevated insulin levels, within 30 minutes of a short period of anaerobic exercise. The degree of hypoglycemia associated with exercise is variable and is only partially responsive to diazoxide. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare familial hyperinsulinism characterized by postprandial hyperinsulinemic hypoglycemia, negative 72-hour fasts, negative preoperative localization studies for insulinoma, and positive selective arterial calcium infusion tests. Histopathological analysis reveals diffuse islet hyperplasia with increased number and size of islet cells. |
Is a |
False |
Hyperinsulinism |
Inferred relationship |
Some |
|
A form of diazoxide-sensitive diffuse hyperinsulinism (DHI) characterized by hypoglycemic episodes that are usually mild, escaping detection during infancy, and usually a good clinical response to diazoxide, (but some are diazoxide resistant). Autosomal dominant hyperinsulinism due to Kir6.2 deficiency usually has a milder phenotype when compared to that resulting from recessive K+ (K-ATP) channel mutations (recessive forms of diazoxide-resistant hyperinsulinism). |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A form of congenital diazoxide-sensitive diffuse hyperinsulinism due to ABCC8 variants and characterized by hypoglycemic episodes that are usually mild, escaping detection during infancy, and usually have a good clinical response to diazoxide. The autosomal dominant hyperinsulinism usually has a milder phenotype when compared to that resulting from recessive potassium (K-ATP) channel mutations. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A form of diazoxide-sensitive diffuse congenital hyperinsulinism due to HNF4A deficiency and, characterised by macrosomia, transient or persistent hyperinsulinaemic hypoglycaemia (HH), responsiveness to diazoxide and a propensity to develop maturity-onset diabetes of the young subtype 1 (MODY). |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A form of diffuse hyperinsulinism due to glucokinase hyperactivity and characterized by an excessive/uncontrolled insulin secretion (inappropriate for the level of glycemia) and recurrent episodes of hypoglycemia induced by fasting and glucose rich meals. The clinical spectrum can range from mild and intermediate cases that respond well to dietary modifications and medical management with diazoxide to severe cases that are unresponsive to diazoxide. The potential development of type 2 diabetes with age is another notable feature. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare diffuse form of congenital hyperinsulinism characterized by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia), chronic hyperammonemia and recurrent episodes of hypoglycemia induced by fasting and protein rich meals. Epilepsy and cognitive deficit, which are unrelated to hypoglycemia but possibly related to the chronic hyperammonemia, may also occur. This disorder is usually responsive to diazoxide treatment. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Hyperinsulinism due to focal adenomatous hyperplasia (disorder) |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare form of congenital diazoxide-sensitive diffuse hyperinsulinism due to short chain 3 hydroxylacyl-CoA dehydrogenase (SCHAD; HADH gene) deficiency and characterized by hyperinsulinemic hypoglycemia with seizures and reported to respond well to diazoxide. It presents with the classical manifestations of hyperinsulinemic hypoglycemia. Exceptional complications include sudden death, and in one case fulminant hepatic failure. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Hyperinsulinism due to HNF1A deficiency is a form of diazoxide-sensitive diffuse hyperinsulinism (DHI), characterized by transient or persistent hyperinsulinemic hypoglycemia (HH) in infancy that is responsive to diazoxide, evolving into maturity-onset diabetes of the young subtype 1 later in life. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare autosomal dominant form of familial hyperinsulinism characterized clinically by postprandial hypoglycemia, fasting hyperinsulinemia, and an elevated serum insulin-to-C peptide ratio, and a variable age of onset. |
Is a |
False |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare form of congenital diazoxide-sensitive diffuse hyperinsulinism due to UCP2 deficiency and characterized by hypoglycemic episodes from the neonatal period, a good clinical response to diazoxide and a probable transient nature of the disease with spontaneous resolution. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Transient neonatal hypoglycemia due to hyperinsulinemia (disorder) |
Due to |
True |
Hyperinsulinism |
Inferred relationship |
Some |
1 |
A rare congenital isolated hyperinsulinism disorder with characteristics of diazoxide unresponsive recurrent episodes of hyperinsulinemic hypoglycemia resulting from an excessive insulin secretion by the pancreatic beta-cells due to SUR1 deficiency. Hypoglycemia may lead to variable clinical manifestations, ranging from asymptomatic hypoglycemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycemic coma or status epilepticus, further leading to poor neurological outcome. Caused by homozygous, compound heterozygous, or heterozygous mutation in the ABCC8 gene on chromosome 11p15. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare congenital isolated hyperinsulinism disorder with characteristics of diazoxide unresponsive recurrent episodes of hyperinsulinaemic hypoglycaemia resulting from an excessive insulin secretion by the pancreatic beta-cells due to Kir6.2 deficiency. Hypoglycaemia may lead to variable clinical manifestation, ranging from asymptomatic hypoglycaemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycaemic coma or status epilepticus, further leading to poor neurological outcome. Caused by mutation in the gene encoding the Kir6.2 subunit of the inwardly rectifying potassium channel (KCNJ11). |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare congenital isolated hyperinsulinism disorder with characteristics of neonatal presentation of severe refractory hypoglycemia in the first two days of life with limited response to medical management sometimes requiring pancreatic resection. Newborns are often large for gestational age with mild to moderate hepatomegaly and diffuse form of hyperinsulinism due to Kir6.2 deficiency. Persistent hypoglycemia, hyperglycemia and type 1 diabetes mellitus may develop later in life. Life-threatening hypoglycemic coma or status epilepticus have also been associated. Caused by mutation in the gene encoding the Kir6.2 subunit of the inwardly rectifying potassium channel (KCNJ11). |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare congenital isolated hyperinsulinism disorder with characteristics of neonatal presentation of severe refractory hypoglycaemia in the first two days of life with limited response to medical management sometimes requiring pancreatic resection. Newborns are often large for gestational age with mild to moderate hepatomegaly and diffuse form of hyperinsulinism due to SUR1 deficiency. Persistent hypoglycaemia, hyperglycaemia and type 1 diabetes mellitus may develop later in life. Life-threatening hypoglycaemic coma or status epilepticus have also been associated. There is evidence the disease is caused by homozygous, compound heterozygous, or heterozygous mutation in the ABCC8 gene on chromosome 11p15. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Hyperinsulinemia due to malignant insulinoma |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Hyperinsulinemia due to benign insulinoma |
Is a |
False |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare endocrine disease characterised by hyperinsulinaemic hypoglycaemia associated with the presence of autoantibodies to endogenous insulin without previous exposure to exogenous insulin. Patients usually present in adulthood with postprandial, fasting or exercise-induced hypoglycaemia, often with pronounced neuroglycopenic symptoms. Laboratory investigations reveal markedly elevated serum insulin, as well as increased C-peptide and proinsulin. The condition may be associated with other autoimmune diseases, monoclonal gammopathy, and/or recent exposure to certain medications. |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
Alstrom syndrome |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|
A rare genetic disease characterized by the association of Fanconi syndrome and nephrocalcinosis in addition to neonatal hyperinsulinism and macrosomia. Patients display a phenotype of proximal tubulopathy characterized by generalized aminoaciduria, low molecular weight proteinuria, glycosuria, hyperphosphaturia and hypouricemia, and additional features not normally seen in Fanconi syndrome (apart from nephrocalcinosis), namely renal impairment, hypercalciuria with relative hypocalcemia, and hypermagnesemia. |
Is a |
False |
Hyperinsulinism |
Inferred relationship |
Some |
|
Familial hyperinsulinemic hypoglycaemia |
Is a |
True |
Hyperinsulinism |
Inferred relationship |
Some |
|